UBS sees a negative catalyst for Carter's (CRI)

Go back to UBS sees a negative catalyst for Carter's (CRI)

Carter's (CRI) sentiment leans bearish, UBS analyst sees a negative catalyst ahead

April 14, 2023 1:45 PM EDT

UBS sees a negative catalyst ahead for Neutral rated Carter's (NYSE: CRI), analyst Jay Sole told investors in his note previewing the company's first-quarter earnings release.

The analyst, who has a $65 price target on the stock, told investors that the firm expects Street EPS estimates to fall and sentiment to... More